Several studies described TP53 gene mutations or loss of heterozygosity (LOH) in CAFs of various human cancers, including breast cancer, and TP53 protein expression in stromal fibroblasts is closely associated with the number of nodal metastases and disease prognosis15–17. This evidence concerns the gene TP53 and breast carcinoma.